05:02 AM EDT, 03/11/2024 (MT Newswires) -- PHAXIAM Therapeutics ( PHXM ) said Monday the planned delisting of its American depositary shares from the Nasdaq Capital Market has taken effect.
The company said it will also deregister its ADSs under the Securities Exchange Act of 1934 to suspend its reporting obligations.